Note: Descriptions are shown in the official language in which they were submitted.
r~
AS~AY ME:T}lOD FOR DETECTING LISTE:RIA
Fiel~ of the Invention
This invention relates to an assay method for
quickly and easily detecting the presence of Listerla
bacteria. In particular, an immunoassay method is
utilized to detect the presence of Listeria strains in
foods and other potentiallv contaminated samples using
an assay characterized by the combined use of
antibodies specific for two separate cell wall
components, namely peptidoglycan and teichoic acids.
Backqround o~ the Invention
The presence of bacterial pathogens is a well
recognized cause of various medical and etiological
problems, so that there i5 an ever present need for the
detection of bacterial pathogens in both clinical
specimens (i.e. blood, tissue, urine and other body
extracts and fluids) and agricultural specimens (such
as food products).
However, current tests for the detection of
bacterial pathogens, such as in food, typically require
a number of days to complete. During this period of
time, between sampling and assay determination, fresh
food and dairy products will enter the food chain and
- 202~2~7
therefore be consumed by the public. If a test
indicates the presence of pathogens, expensive product
recalls may result, or, worse, before the test results
are discovered an outbreak of sickness may occur.
This was exactly the case in a number of recent
outbreaks of Listeria in fresh dairy and vegetable
products. In the case of Listeria, an outbreak
generally produces a death rate greater than 40%. In
addition this rate is much higher for newborns,
pregnant women, the elderly and immunocompromised
individuals. Spontaneous abortions result even in
otherwise asymptomatic patients. In ~act, it is
estimated that as many as 2% of all spontaneous
abortions may be due to Listeria infection.
As stated above, traditional methods to detect the
presence of bacterial food pathogens require an
extended period of time, basically due to the need for
an incubation period. This incubation period is
intended to allow for recovery of injured bacteria,
growth of these bacteria from a bacXground of competing
microorganisms and an increase in bacterial cell
numbers to more readily aid in identification. In many
cases a series of two or thres separate incubations is
needed to isolate the target bacteria.
2~2~C~7
In the standard FDA procedure for detection of
Listeria in food products (Bacteriological Analytical
Manual, 6th ed., 1984; Supplement, September l9B7,
Chapter 29) 25 g or 25 ml of a food sample is mixed
with 225 ml of enrichment broth. This sample in broth
mixture is incubated for 7 days. At the end of days 1
and 7 a sample of the broth culture is strea}ced onto
petri plates containing selective growth agar and these
plates are incubated for an additional 2 days.
Identification of Listeria colonies confirms the
presence of Listeria in the original food sample. This
identification, however, is subjective, and there~ore
prone to misinterpretation, and this procedure re~uires
a minimum of 7 days to confirm Listeria negative
samples.
These conventional methods are slow, requiring 5-
14 days, or more, depending upon the bacteria species
of interest. In a given food sample it is also
possible to miss targ~t bacteria (false negatives) due
to many reasons including inadequate incubation
conditions (time, growth media), subjectivity of the
person interpreting the results, identification on
petri plates, over-growth by competing organisms or a
combination of these and other problems.
2~262~7
More recent methods of bacterial detection in food
products have utilized immunoassays. Antibodies to an
antigen present in the bacteria of int~rest are
generally used in these methods :in some form of a two
site assay. That is, one antibody is immobilized and
acts to capture the target bacterial antigens. This
allows for separation of the target antigen from the
food sample. A second antibody to this antigen (having
the same or a different epitope) is labeled in some
fashion such as radioactively with I125 or enzymatically
with horse radish peroxidase, and when added to ths
immobilized antibody antigen complex is also
immobilized. Subsequent steps remove unbound labeled
antibody. The label left attached is measured and
usually compared against standards (positive and
negative controls~ to determine thP presence of the
target bacteria. At least one of the two antibodies
used in the two site assay must be specific to the
target bacteria. This type of immunoassay is known as
a direct assay. Other forms, such as the competition
assay are also used but tend to be less sensitive.
Because of the actual sensitivity limit of these
assays it remains necessary to culture the target
bacteria from the food sample. In some of the n~wer
2~2~2~
immunoassay tests incubation times have been reduced
and the number of separate incubation steps have also
been reduced. The resulting tests, however, still
require about 48 hours to complete. Many of the
problems associated with culturing the target
organisms, as described above, also remain.
In a generalized "rapid" immunoassay for detection
of Listeria, 2S g or 25 ml of food sample is mixed with
225 ml of enrichment broth, as in the FDA procedure.
This culture mixture is incubated for 24 hours. From
this 250 ml of culture, 1 ml is removed and added to 9
ml of selective growth medium. This selective culture
mixture is incubated for an additional approximately 24
hours. At this point, depending upon the actual
immunoassay format, some fraction of the total 10 ml
subculture (usually 0.2 ml - 1.0 ml~ is tested by
immunoassay for the presence of Listeria.
In summary, these existing ~rapidn immunoassay
procedures for bacterial detection in food samples all
require at least one (usually two or more) dilution of
sample step (into growth medium) followed by an assay
procedure which only utilizes a fraction of this final
culture. The actual assay sample thus only corresponds
to a small fraction of the original food sample. The
2~2~
bacterial culture step, or steps, must therefore
overcome this dilution factor, adding to the amount of
needed culture time.
These and other disadvantages of the prior art
methods are overcome by the present invention which
provides a fast and accurate method for the detection
of Listeria.
Ob;ects and ~ummary of the Invention
It is, therefore, one object of the present
invention to provide a method for quickly detecting the
presence of bacterial pathogens.
It is another object of the invention to provide a
method for the detection of Listeria bacteria which
requires little or no culturing of the bacterial cells.
It is a further object of the invention to provide
a rapid method for the detection of Listeria.
It is a still further object of the invention to
quantitate the number of Listeria cells in a sample.
These and other objects of the invention are
accomplished by providing a method which selectively
removes bacteria from a sample by the use of an
antibody, lyses the captured cells to release
peptidoglycan-teichoic acid (PEP-TA) complexes of the
bacterial cell walls, captures the released complexes
2~6~ ~7
by the use of a second antibody, and then detects the
presence of the ~EP-TA complexes by the use of a
labeled antibody which is specific for teichoic acid
and can subsequently be detected to indicate the
presence of the bacterial pathogen.
Detailed De~cription of th3 In~en~ion
As noted above, one object of the present
invention is to provide an immunoassay procedure for
rapid identification of Listeria strains in food
samples requiring little or no culturing of the
bacterial cells. This allows for interpretation of
test results prior to release of fresh food pxoducts.
The present invention overcomes the dilution factor
effect by using magnetic bead capture or affinity
column technology to concentrate the target bacteria
directly from liquid, or liquified food samples. Once
concentrated and separated from the food sample,
further steps are used to detect the captured bacterial
cells. If, for sensitivity of detection, a culturin~
step is necessar~, the addition of a small volume of
non-selective growth medium to the separated magnetic
beads or directly to t~e affinity column and a short
incubation step will rapidly lead to the increase in
cell number necessary for detection for certain
- 2~2~2~7
bacterial species. The present invention will also
allow for a standard incubation step in enrichment
broth, followed (without a selective growth step) by
the assay procedure as described below.
After the bacteria are immobilized and
concentrated according to the invention, the bacterla
are treated with cell wall lytic enzymes, or with other
methods to in general disrupt cell walls or cellular
integrity. The products of this cell wall digestion
are then chosen to be the bacterial identification
antigens to be selectively identified by antibody
assay. The result of releasing these antigens is
exposure and accessibility of far more of these target
antigens $han would be possible utilizing whole
bacterial cells as detection targets. Selectivity of
the assay is achieved through the specificity of the
antibodies used, as well as the means used to release
the target antigens from whole bacterial cells.
Another object of the prPsent invention is to
increase sensitivity of immunoassays used for bacterial
detection. As stated above, one way of doing this is
to utilize as many antigenic determinants as possible
by making them accessiblP to the antibodies. Another
way to increase sensitivity is to choose antigen
2~2~2~7
targets with the maximum number of antigenic
determinants per bacterial cell as possible while still
maintaining overall specificity. In the specific
example described below, these two aspects o~ the
invention are combined for increalsed sensitivity.
The method of the invention, therefore, generally
comprises the following procedural steps:
1) The sample to be tested for the presence of
bacterial pathogens is, if necessary, liquified.
2) The liquified sample is combined with a solid
matrix having immobilized thereon mono~lonal or
polyclonal antibodies to the target bacterial cells.
If present the target bacterial cells are thereby
immobilized to the solid matrix. The solid matrix with
immobilized cells attached is then washed to remoYe the
remainder of the food sample.
3) The immobilized cells (captured by the
antibodies) are treated to release target antigens,
i.e. peptidoglycan-teichoic acid complexes, from the
cell walls.
4) The thus treated complexes are combined, such
as by passing through an affinity column, with an
affinity matrix having bound thereto antibodies to the
- 2~2~2~7
peptidoglycan (PEP) moiety, whereby the peptidoglycan
moiety is captured by the antibodies.
5) A solution containing Labeled antibodies to
the teichoic acid (TA) moiety of the PEP-TA complex is
combined with the column matrix whereby these labeled
antibodies bind to the teichoic acid portion of the
captured PEP-TA complexes.
6) The aEfinity matrix is then treated with a
releasing a~ent to release the label from the matrix,
or break any part of the linkage to the matrix; and the
presence of labeled monoclonal antibodies is detected
as a direct indicator of the presence of the bacterial
pathogen.
As can be seen from the above method scheme, the
method of the invention is particularly characterized
by the use of an antibody to first select out bacteria
from a sample, and the US2 of two additional antibodies
which are selective for a particular cell wall
component of,the selected bacteria. Utilizing these
characteristic features, the method of the invention
can ~e importantly applied to the rapid detection OI
Listeria strains~ quantitation of the number of
Listeria strain cells in a sample, and (if desired) to
selective identification of Listeria strainsO
20262 L~
As noted above, one characteristic feature of the
method of the invention is the use of the PEP-TA
complex as a capture-target antigen group to
selectively detect the presence of Listeria strains,
taking advantage of the fact that Listeria strains
contain a number of differing teichoic acids. The cell
wall of Listeria strains is composed of diaminopimelic
type peptidoglycan, ribitol containing teichoic acid,
lipoteichoic acid and protein. The general
organization of these cell wall components was
described by Fiedler, F. (1988) in Infection 16, Suppl.
2, pp. 392-397 and is shown in Figure 1.
As can be seen in Figure 1, the cell wall includes
a peptidoglycan matrix to which are bound a large
number of teichoic acid molecules. An example of the
chemical structure of a portion of the peptidoglycan
matrix covalently attached to an individual teichoic
acid molecule in one Listeria strain is shown in Figure
2. The teichoic acid molecule includes a sugar moiety
comprised of ribitol or a substituted ribitol. In a
single teichoic acid molecule, an individual ribitcl or
substituted ribitol is repeated approximately 30 times.
In addition, there are differences in the sugar
substitution to the ribitols in dif~erent strains of
2 ~
12
Listeria. These differences in the ribitol
substitution among strains o~ Listeria are shown in
Figure 3.
The present invention takes advantage of these
structural characteristics of the listeriae bacterial
cell wall to provide an assay method which is capable
of detecting the presence of Listeria strains, and, if
desired, is able to distinguish between strains of
Listeria. Since only some Listeria strains are known
to be pathogenic it is possible to detect only the
pathogenic strains, utilizing to advantage the
characteristic teichoic acid structure of those
strains.
In particular, with reference to Fig. 3 showing
the ribitol substitutions for different Listeria
strains, strains SV 1/2a and 4b are the most common
pathogenic strains; SV 5 is primarily an animal
pathogen, and the remaining strains are rarely
pathogenic.
Detection and selection of the bacteria and cell
wall components is accomplished by the use of
antibodies. Either polyclonal antibodies or monoclonal
antibodies can be used in the individual steps of the
assay, depending upon various factors, including the
2~26~7
degree of sensitivity desired. If polyclonal antibodies
axe to be used, then such antibodies can be prepared
according to ~ se known procedures~ For example,
procedures such as those described by Hurn, B.A. et al.
(1980) in Meth. in Enzymology, Ed. Van Vurakis, Ho and
Langone, J., pp. 104-142, can be used.
The preparation of monoclonal antibodies is known
and the monoclonal antibodies used in this invention
are prepared using the method originally authored by
Milstein and Kohler and published in Nature (1975),
256, pps. 495-497. The basic process involves
injecting an animal, usually a mouse, with an
immunogenic substance. After suitable time for
antibody production to the immunogen, the mouse is
sacrificed. Cells are removed from the spleen and
fused with myeloma cells. Hybridoma cells resulting
from this fusion are able to reproduce in vitro, and
each expresses genetic information for one specific
antibody. The antibodies produced from one hybridoma
fusion thus will only recognize a single antigenic
determinant of the immunogen.
Cells cultured from individual hybridoma cells are
screened for production of antibodies to the target
antigenic determinant. Those hybridomas positive for
- 202~2ll~
the target antigen are further screened to identi~y
those having the highest affinity. The monoclonal
antibodies used in the present invention will have an
affinity of at least 108 liters/mole. Monoclonal
antibodies displaying all of these characteristics are
then screened using actual assay conditions to
determine if the assay condition alters the antibody
binding characteristics or affinity, and to screen out
those with cross reactivity to possible contaminating
antigens.
In the assay method of the invention, three
different antibodies are utilized to provide the
specific selection and detection desired~ an
antibody directed to Listeria cells; (2) an antibody
directed to the peptidoglycan component of the cell
walls; and (3) an antibody directed to the teichoic
acid component of the cell walls.
Monoclonal antibodies directed against Listeria
cell surface antigens are made by first culturing
cells. Attenuated extracts of these cells are then used
to immunize mice and the standard procedure for
hybridoma production and monoclonal antibody cloning
and screening is followed as dascrihed above.
2~2~ 7
Monoclonal antibodies directed against Listeria
cell wall teichoic acids are also produced by methods
familiar to those in the field. Immunization is
carried out using Listeria cell wall preparations made
by the method of Schleifer, K.H. and Kandler, O.;
(1967~ Arch. Mikrobiol. 57, 335~363. These cell wall
preparations contain (TA) covalently linked to the cell
wall peptidoglycan matrix. For immunization the
peptidoglycan will act as the immunogenic carrier.
Greater antibody spPcificity may be achieved by using
purified (TA) as the immunizing agent. For this, the
cell walls may be digested chemically (for example with
10 mM glycine hydrochloride buffer pH 2.5). The (TA)
is then purifiPd and used as the immunogen. To
increase the immune response these purified (TA) may be
coupled to an immunogenic carrier protein. For
example, the reducing sugar end-group of the digested
(TA), as above, may be coupled to a carrier protein by
reductive amination using the method of Roy et al.
(1984) ~ , 62, 270-275, as applied
to Listeria (TA) by Kamisango et al. (19S5), J. Clin.
Microbiol., 21, 135-137. In this procedure (TA) are
reacted with a carrier protein such as BSA in the
presence of sodium cyanoborohydride. The result is a
'~02~2~7
16
covalent teichoic acid-protein complex which is used
for immunization~
Monoclonal antibodies directed against cell wall
peptidoglycan (PEP) are made by preparing cell walls as
above. Treatment of the cell walls with 10 mM glycine
hydrochloride buffer, pH 2.5, followed by
centrifugation results in the separation of (TA) into
the supernatant and insoluble (PEP) in the pellet.
This pellet is resuspended and used as the immunogen.
Also possible is further purification of the (PEP) by
HPLC or electrophoresis, and the use o~ purified
cleavage fragments from the (PEP) matrix. Using
fragments of (PEP) as immunogens was demonstrated by
Wergeland, H.I., et al. (1987) J. of Immunol. Meth.,
104, 57-63.
Monoclonal antibodies to the cell wall
peptidoglycan can also be prepared according to the
procedure described in U.S. Patent No. 4,596,769 to
Schockman et al.
The thus prepared monoclonal antibodies ara
utilized according to the invention in an assay to
selectively capture Listeria cells from a sample to be
tested, and then to selectively identify the presenca
of one or more strains of I.isteria utilizing the
2~262~
characteristic teichoic acid structures of the
individual strains. The assay can be performed
according to various types of assay procedures. In
particular, the preferred methods of capturing the
Listeria cells and Listeria antigens are by magnetic
bead capture or affinity column chromatography.
However, any other method able to utilize the
immobilized antibodies to capture and concentrate the
cells and released target antigens is ~easible. This
would include the use of suspended beads in liquified
samples to capture the targets, followed by
centrifugation to concentrate the target cells or
antigens. Also included is collection of target cells
or antigens on sticks or paddles coated with
immobilized antibodies and stirred through liquid or
liquified samples. In addition methods utilizing
filtration of the sample through membranes (listed
above) having antibodies attached is included.
The preferred immobilizing matricies for the
capturing antibodies are magnetic beads or
polyacrylamide beads. However, any other matrix for
immobilizing antibodies is feasible. These include
beads of agarose or other polysaccharides, cross-linked
dextrans, glass beads, latex beads, glass fiber
292~s2l~
filters, cellulose nitrate filters and nylon filters.
Methods to bind antibodies to polyacrylamide beads and
other matrices are well known to those in the
profession. Carbodiimides may be used to couple
antibodies to polyacrylamide beads as described by
Bauminger, J., and Wilchek, M. 1980, Methods of
Enzymology, 70, 151-159. Another example is a method
for generally binding biopolymers to polysaccharides,
U.S. Patent No. 3,645,852.
In one preferred form of the invention, the
antibodies, particularly antibodies to the PEP are
immobilized on magnetic beads. This can be
accomplished by procsdures which are Per se known, such
as those described in U.S. Patent No. 3,970,518; No.
4,018,886, No. 4,855,045 and No. 4,230,685. In a
particular preferred embodiment, attachment of
antibodies to magnetic particles is accomplished
through a Protein A intermediate. That is, Protein A
is first attached to the magnetic particles and the
antibodies of choice are then bound to the Protein A.
The use of the Protein A intermediate greatly increases
the effectiveness of capture by the attached
antibodies. (Forsgren et al. (1977) J. Immunol. 99:19)
Protein A attaches to the Fc portion of IgG subclass
2~2~2~7
antibodies, thus extending and presenting the Fab
portion of these antibodies. The resulting correct
orientation of the antibodies and extension a~ay from
the particles leads to a very effective interaction
between the bound antibodies and their target.
The method of attachment of Protein A to magnetic
particles may proceed by any of several processes
available through the scientific literature. In one
such procedure, magnetic iron oxide particles of
approximately 1 micrometer diameter are chemically
derivatized by reaction, first with 3-aminopropyltri-
ethoxysilane, then with glutaraldehyde. The
derivatized magnetic particles are then mixed with
Protein A resulting in a maynetic particle to which
Protein A is covalently attached. The antibodies are
now added to the Protein A magnetic particles and after
a short incubation the protein A-antibody complexes
form. tWeetall, H.H. ~1976) Meth. in Enzvmol. 44:134-
148) These derivatized particles with Protein A-
antibodies attached are now ready for use in bacterial
cell capture.
. , .
202~2~7
GENERAL DESCRIPTION OF THE METHOD OF THE INVBNTION -
EXAMPLE FOR LISTERIA STRAIN DETECTION
Step 1): As a first step, if the sample (such as
food) is not a liquid, the food sample is mixed with
liquid, such as water, and blended to liquify. The
liquid or liquified food sample is filtered through a
course paper, glass or other matrix filter to remove
particulates. If an environmental sample, swabs or
scrapings of the tested surface are mixed in a
collection buffer and then treated as a liquified food
sample.
Alternatively, the sample is treated as in the
standard FDA or generalized "rapid~ immunoassay
procedures through the enrichment broth culture step.
A standard volume of this culture is then filtered and
used in place of the original food or environmental
sample.
Ste~ 22: Immobilized antibodies (polyclonal or
monoclonal) to target bacterial cells are used to
separate Listeria cells from the sample filtrate. In
this step, one or more antibodies must be used to
recognize all target strains of the genus Listeria.
Recognition of other bacteria (i.e., cross-reactivity)
2~2~2'17
21
can be accepted in this step, as complete specificity
is not necessary at this step of the assay.
The antibodies used in step (2) recognize Listeria
cell surface antigens, and these antibodies are
immobilized on magnetic beads. These antibody coated
magnetic beads are added directly to a liquid food
sample or filtered liquified sample. After a short
incubation step the beads with Listeria cells
immobili~ed thereon, if present in the sample, are
separated from the sample matrix by use of a magnetic
field. Subsequent washing and immobilization steps are
followed by suspension of the Listeria cells
immobilized on the magnetic beads, in a small volume of
cell lysis solution as described in step (3).
Alternatively, polyacrylamide beads coated with
Listeria cell surface antibodies are used to immobilize
Listeria cells packed into a liquid chromatography
column or small syringe barrel. As shown in Figure ~,
the sample filtrate is passed through a column (Column
#1) 1 and over the immobilized antibody coated beads 2.
The cell surface antibodies capture Listeria cells
while the sample filtrate passes through Column ~1.
After washing the column, the target Listeria cells
2~2So~7
have been concentrated on Column #1 and separated from
the food sample.
step 3): The immobilized cells are treated by
enzymatic means to release target antigens from the
cell wall or some other cellular structure.
Specifically, i~nobilized Listeria cells are digested
in a small volume (<1 ml) of solution containing a
lysis enzyme, such as mutanolysin. The product of this
digestion is individual and/or multiple units of cell
wall peptidoglycan covalently linked to cell wall
teichoic acid. These peptidoglycan-teichoic acid
complexes tPEP-TA) are the bacterial target antigens
for the immunoassay. A degree of enrichmPnt is
achieved in this step as limited bacterial types are
digested by mutanolysin. Cells captured but not
digested remain whole and immobilized. No potential
target antigens are released from these undigested
cells.
Ste~ 4L: Antibody coated magnetic baads are then
separated from the solution (containing the Listeria
PEP-TA complexes) with a magnetic field. This solution
is removed and applied directly to Column (Column #2)
3. Alternatively, if capture of the Listeria has taken
place utilizing Column (Column #l) 1, a second affinity
202~2~7
column (Column ~2) 3 is then attached to the bottom o~
(Column #1) (See Figure 4). Affinity Column #2
contains immobilized monoclonal or polyclonal
antibodies to the peptidoglycan moiety of the PEP-TA
complex covalently attached to agarose beads 4.
Digested bacterial cell wal:L components are passed
over Column #2 either directly through a slip luer
connection 5 between the two columns, or the cell wall
digestion solution of Column #1 can be collected and
subsequently transferred to Column #2 as is the case
when magnetic beads are used. In either case, the free
PEP-TA units are captured by immobilized peptidoglycan
(PEP) antibodies. A buffer solution is washed through
the column to remove all remaining cellular components
except the captured PEP-TA complexes.
Step 5): A solution containing monoclonal
antihodies to Listeria teichoic acid (TA) is added to
Column #2. These antibodies are specific to Listeria
strains. As noted above and shown in Figure 3, the
structure of TA varies among the strains of Listeria
and, thus, more than one antibody is required ~or
detection of the entire Listeria genus. On the other
hand, i~ any selected strains are to be identified, the
antibodies to any of these strains can be used. These
- 2(~2~2~7
24
antibodies are labeled directly, or indirectly with
detector molecules.
After passing this solution over Column #2 the
column is washed thoroughly to remove all labeled
antibody not specifically attached to the TA moiety of
the PEP-TA complex.
Final specificity of the test is accomplished at
this step of the procedure.
Step 6): A small volume of a releasing solution
is passed over Column #2 to ralease the detector
molecules attached to the TA antibodies, or labeled TA
antibodies.
Ste~_7): The releasing solution containing the
released detector molecules is collected and the amount
of label is measured. This measurement can either be a
direct indicator of the presence of Listeria strains or
can be compared against a set of control columns.
These steps are schematically summarized in ~igure
5.
According to the above procedure, all of the
target listeriae cells from a given food sample are
potentially captured by the magnetic beads or on Column
#1. All of the target antigens released from these
cells are then potentially captured on Column #2.
2O2~2L~7
Finally all of the (TA) from the original captured
cells (representing all of the cells in the food
sample~ become targets for signal antibodies. In other
prior art methods, such as both the standard FDA and
the new nrapid~ immunoassay methods, onlv a small
fraction of the original sample, and therefore a small
fraction of the I,isteria cells from the sample, is used
in the assay. These prior tests may use 1/25,000 to
1/5000 of the original sample and cells. Thus, these
methods rely upon growth of the cells at each stage to
rebuild the cell number for the final c211
identification or immunoassay. The present invention
immediately concentrates the bacteria in the original
food sample, potentially capturing all o~` the target
cells in the sample, and therefore doas not rely upon
extended incubation for increasing cell number. Also,
because no incubation or dilution steps are involved,
under conditions whereby the detection system used is a
direct label system or system with a known signal
amplification, the observed detection level can be
related to a quantitative number of List~ria cells in
the original sample. This only applies to objectives
of the invention not requiring incubation of the
sample.
2~2~2~
26
U.S. Patent No. 4,556,769 noted above describes an
assay method using monoclonal antibodies to
peptidoglycan. However, the present invention
importantly uses as the final detection step the use of
labeled antibodies against teichoic acid. Since there
are approximately 30 ribitol units per (TA) molecule,
and between an equal numher and four times the number
of (PEP) disaccharide-peptide repeating units as (TA)
molecules in each listeriae cell, the assay of the
invention permits targeting of about 8 to 30 times as
many antigenic sites, thereby enhanciny assay
sensitivity. Using the (TA) moiety of the PEP-TA
complex as the labeled antibodies target also allows
for Listeria strain identification, and thus pathogenic
vs. nonpathogenic Listeria. This would not be possible
if (PEP) alone were used to assay for Listeria strains.
In fact Listeria strain identification is not possible
if only cell wall (PEP) is used for a target as other
gram positive and most gram negative bacteria share the
same (PEP) chemical structure as Listeria (Schleifer,
K.H. and Kandler, O., (1972) Bacterioloqical Reviews,
36, p. 404-477). Therefore, the antigenic epitopes are
essentially the same.
2~2 l~ 7
Other prior art methods also rely upon an
incubation step for selective growth of the listeriae
or other target bacteria from a background of competing
microorganisms. The present invention eliminates
competing microorganisms by a series of cell separation
and specific cell lysis steps.
Prior art methods requiring culturing can only
detect viable cells able to reproduce during the
incubation stepsO Enough cells must recover and
reproduce to overcome the cell dilution factor
described above and increase the cell number to a level
detectable by the assay. The present method is a~le to
detect both viable and nonviable cells. To determine
if a Listeria positive food or environmental sample
contains viable or nonviable cells parallel tests are
conducted. In the first test the sample is processed
as described above without a short (<6 hr.) incubation
step. In the second test an equal amount of filtered
sample, from the same original sample, is processed to
capture the Listeria cells and washed as described
above. A small volume of growth medium is added to the
separated magnetic beads or added directly to column #1
and the cells are then incubated. The remainder of the
assay procedure as described above is then followed. A
202~247
28
statistically significant increase in tha detected
target antigen level will indicate that viable cells
were present in the original sample. Alternatively, if
the one step enrichment culture step is used, after
making the sample dilution into enrichment broth a
standard volume of this broth sample mixture is
immediately processed through the assay. After
incubation an equal volume of broth sample mixture
again is processed through the assay. A comparison of
label signals, before and after incubation, is an
indication of the presence of viable Listeria or other
target bacteriaO
As noted above, the assay of the present invention
importantly avoids the use of a time consuming
bacterial culturing step. However, if the needed
sensitivity of the test is not achieved without
culturing the Listeria cells, or if cell viability is
to be tested, a short incubation of the cells while
attached to Column #1 or after separation and
concentration using antibody coated magnetic beads can
be carried out after step (2) described abo~e. This
culturing, howevPr, should be understood as
distinguishable from other prior art incubation
procedures. Prior procedures involved standard cell
2~2'~
29
culturing in, for example, containers with bacterial
broth~ A culturing process according to the present
invention, on the other hand, cultures and grows the
cells as they are attached to a solid matrix ~ia an
appropriate antibody. Culturing according to this
procedure, more quickly enhances, the number of target
cells to be identified, because potential competing
bacteria have been removed from the column.
To demonstrate the possibility of growing Listeria
cells in this manner, cells (strain 1/2a),
radioactively labeled with 32p, are cultured overnight
at 37C to a cell density of approximately 1 x 108
cells per ml. Subsequently 1 x 107 cells are passed
over a column containing 0.2 ml bed volume of agarose
beads with wheat germ lectin attached. Wheat germ
lectins bind to bacterial cell surface sugars.
Although inefficient at capturing the Listeria cells,
approximately 10%, or 1 x 106 cells, are captured by
the agarose immobilized lectins. After washing the
column with Tris-HCl pH 6.4 plus 10 mM NaCl, 1 ml of
brain-heart infusion medium is added to the column and
with positive pressure forced to enter and surround the
agarose beads. Approximately 0.1 ml of liquid is
2~2~2'~7
allowed to drop from the column. This liquid is
counted for 32p and found to contain very few cells.
The column is then capped at the bottom and top
and is placed in a 37C incubator. After approximately
10 hours incubation the medium is pushed through the
column and collected along with L ml of fresh medium as
a washO The optical density as a measure of this
collected material is determinedO The result is an
increase in listeriae cells to approximately 1 x 108
cells. This is a 100 fold increase. Microscopic
examination of the cells reveals the vast majority to
be characteristic of Listeria strains.
In the above described procedure, particularly at
step (7), antibodies directed against listeriae (TA)
serve as the signal or de~ector antibodies. Thes~ are
labeled either directly or indiractly with labels used
in other known immunoassays. Direct labels (labels
attached directly to the anti (TA) antibodies) may
include fluorogenic, chemiluminescent, bioluminescent,
radioactive, metallic, biotin or enzymatic molecules.
Methods of combining these labels to antibodies are
well known to those in the art. Examples include the
method of Hijmans, W. et al. (1969), Clin. Exp.
Immunol. 4, 457-, for fluorescein isothiocyanate, the
2 ~
31
method of Goding, J.W. (1976), J. Immunol. Meth. 13,
215 for tetramethylrhodamins isothiocyanate, and the
method of Engrall, E. (1980), Meth. in Enzymol. 70,
419-439 for enzymes.
These (TA) detector antibodies may also be labeled
indirectly. In this case the actual detection molecule
as described above is attached to a secondary antibody
or other molecule with binding affinity for the anti
(TA) detector antibody. If a secondary labeled
antibody is used it is preferably a general antibody to
a class of antibody from the animal species used to
raise the (TA) monoclonal antibodies. In this case the
immobilized antibody to (PEP) would of necessity be
raised in another animal host or be of a different
antibody class or fraction of the same class of
antibody. Another example of indirect labeling is
covalent coupling of biotin to the ~TA) monoclonal
antibodies. Subsequent addition of avidin-biotin
conjugates produced by the method of Bayer, E.A.
(1979), Meth. in Enzymol. 62, 308-, or strepavidin-
biotin conjugates, whera the biotin is labeled, and
binding o~ these conjugates to the ~TA) antibody~biotin
complex provides the detection label.
2 ~ 2 '~ 7
32
Release of the label from Column #2 may be
achieved by the use of an organic solvent (such as
methanol or acetone), or an aquec~us solution containing
an agent to disrupt the binding of the label, or any
part of the connection between the immobilizing agent
and the label. organic-aqueous mixtures may also be
used. Aqueous agents may include solutions of high or
low pH, inorganic salts, detergents such as sodium
lauryl sulEate, and chaotropic agents such as guanine
or urea.
